X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (913) 913
index medicus (753) 753
hiv infections - drug therapy (704) 704
infectious diseases (685) 685
male (525) 525
female (523) 523
hiv (509) 509
adult (485) 485
antiretroviral therapy (400) 400
hiv infections - virology (386) 386
immunology (353) 353
virology (343) 343
middle aged (338) 338
pharmacology & pharmacy (326) 326
anti-hiv agents - therapeutic use (324) 324
hiv-1 - drug effects (298) 298
hiv-1-infected patients (275) 275
human immunodeficiency virus--hiv (275) 275
viral load (262) 262
hiv infection (255) 255
drug therapy (243) 243
hiv-1 - genetics (240) 240
antiretroviral drugs (233) 233
microbiology (230) 230
protease inhibitors (229) 229
naive hiv-1-infected patients (227) 227
naive patients (222) 222
antiviral agents (218) 218
treatment outcome (217) 217
drug resistance (203) 203
mutation (194) 194
cd4 lymphocyte count (193) 193
hiv-1 (190) 190
highly active antiretroviral therapy (189) 189
research (184) 184
drug resistance, viral (179) 179
efavirenz (179) 179
aids (178) 178
efficacy (178) 178
treatment-naive (174) 174
safety (171) 171
anti-hiv agents - administration & dosage (162) 162
double-blind (162) 162
health aspects (160) 160
anti-hiv agents - adverse effects (159) 159
therapy (159) 159
tenofovir (156) 156
aids/hiv (152) 152
acquired immune deficiency syndrome--aids (147) 147
hiv-infected patients (146) 146
treatment-naive patients (145) 145
human immunodeficiency virus (144) 144
active antiretroviral therapy (142) 142
hiv infections - immunology (137) 137
research article (136) 136
drug therapy, combination (135) 135
antiretroviral therapy, highly active (134) 134
hiv-1 - isolation & purification (129) 129
human-immunodeficiency-virus (127) 127
young adult (127) 127
medicine (126) 126
drug resistance, viral - genetics (120) 120
infection (120) 120
reverse transcriptase inhibitors - therapeutic use (120) 120
genotype (119) 119
combination therapy (118) 118
prevalence (117) 117
virus diseases (117) 117
analysis (115) 115
antiretroviral agents (115) 115
lamivudine (114) 114
patients (114) 114
reverse-transcriptase inhibitors (114) 114
adolescent (112) 112
hiv infections - epidemiology (111) 111
dosage and administration (110) 110
immunodeficiency-virus type-1 (110) 110
naive (109) 109
risk factors (109) 109
multidisciplinary sciences (108) 108
care and treatment (107) 107
anti-hiv agents - pharmacology (106) 106
emtricitabine (106) 106
raltegravir (104) 104
rna, viral - blood (103) 103
mutations (98) 98
science (98) 98
viruses (96) 96
aged (94) 94
initial treatment (94) 94
antiretroviral therapy, highly active - methods (92) 92
ritonavir (92) 92
drug-resistance (90) 90
reverse-transcriptase (90) 90
treatment-experienced patients (90) 90
cohort studies (89) 89
acquired immune deficiency syndrome (88) 88
clinical trials (87) 87
hiv protease inhibitors - therapeutic use (86) 86
infected patients (85) 85
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1170) 1170
Spanish (24) 24
German (4) 4
French (3) 3
Russian (2) 2
Italian (1) 1
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
AIDS, ISSN 0269-9370, 08/2014, Volume 28, Issue 13, pp. 1903 - 1910
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 2018, Volume 13, Issue 6, pp. e0198768 - e0198768
Background Long-term combination antiretroviral therapy often results in toxicity/tolerability problems, which are one of the main reasons for switching... 
TREATMENT-NAIVE | SAFETY | MULTIDISCIPLINARY SCIENCES | NON-INFERIORITY TRIAL | ANTIRETROVIRAL THERAPY | OPEN-LABEL | DOLUTEGRAVIR | TOXICITY | TENOFOVIR | BOOSTED PROTEASE INHIBITOR | HIV-INFECTED PATIENTS | HIV-1 | Raltegravir Potassium - adverse effects | Follow-Up Studies | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Raltegravir Potassium - therapeutic use | Male | Treatment Outcome | Lamivudine - adverse effects | Lamivudine - therapeutic use | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Dideoxynucleosides - adverse effects | Dideoxynucleosides - therapeutic use | Retrospective Studies | Drug Therapy, Combination | Drug Combinations | Treatment outcome | Analysis | Abacavir | Lamivudine | Dosage and administration | Drug therapy | Comparative analysis | HIV infection | Raltegravir | Slopes | Toxicity | Liver | Medical services | Clinical trials | Population studies | Infections | Males | Medical diagnosis | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Safety engineering | Human immunodeficiency virus--HIV | Failure | Antiretroviral drugs | FDA approval | Ribonucleic acid--RNA | Patients | Antiretroviral therapy | Switching | CD4 antigen | Clinical medicine | Index Medicus | RNA | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 09/2010, Volume 55, Issue 1, pp. 39 - 48
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 05/2012, Volume 60, Issue 1, pp. 33 - 42
Journal Article
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, ISSN 0305-7453, 04/2017, Volume 72, Issue 4, pp. 1163 - 1171
Background: Combination ART (cART)-related toxicities and costs have prompted the need for treatment simplification. The ATLAS-M trial explored 48 week... 
TRIPLE TREATMENT | INFECTIOUS DISEASES | EFFICACY | EMTRICITABINE | NON-INFERIORITY TRIAL | PROTEASE INHIBITOR MONOTHERAPY | MICROBIOLOGY | OPEN-LABEL | HIV-INFECTED PATIENTS | THERAPY | PHARMACOLOGY & PHARMACY | NAIVE ADULTS | DUAL TREATMENT
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 4/2009, Volume 63, Issue 4, pp. 795 - 804
Journal Article
by Fourati, Slim and Charpentier, Charlotte and Amiel, Corinne and Morand-Joubert, Laurence and Reigadas, Sandrine and Trabaud, Mary-Anne and Delaugerre, Constance and Nicot, Florence and Rodallec, Audrey and Maillard, Anne and Mirand, Audrey and Jeulin, Hélène and Montès, Brigitte and Barin, Francis and Bettinger, Dominique and Le Guillou-Guillemette, Hélène and Vallet, Sophie and Signori-Schmuck, Anne and Descamps, Diane and Calvez, Vincent and Flandre, Philippe and Marcelin, Anne-Genevieve and Lagier, E and Roussel, C and Le Guillou, H and Alloui, C and Bettinger, D and Pallier, C and Fleury, H and Reigadas, Sandrine and Bellecave, P and Recordon-Pinson, P and Payan, C and Vallet, S and Vabret, A and Henquell, C and Mirand, A and Bouvier-Alias, M and de Rougemont, A and Dos Santos, G and Morand, P and Signori-Schmuck, A and Bocket, L and Rogez, S and Andre, P and Tardy, J.C and Trabaud, M.A and Tamalet, C and Delamare, C and Montes, B and Schvoerer, E and Ferre, V and André-Garnier, E and Cottalorda, J and Guinard, J and Guiguon, A and Descamps, D and Brun-Vézinet, F and Charpentier, C and Visseaux, B and Peytavin, G and Krivine, A and Si-Mohamed, A and Avettand-Fenoel, V and Marcelin, A.G and Calvez, V and Lambert-Niclot, S and Soulié, C and Wirden, M and Morand-Joubert, L and Delaugerre, C and Chaix, M.L and Amiel, C and Schneider, V and Giraudeau, G and Brodard, V and Maillard, A and Plantier, J.C and Chaplain, C and Bourlet, T and Fafi-Kremer, S and Stoll-Keller, F and Schmitt, M.P and Barth, H and Yerly, S and Poggi, C and Izopet, J and Raymond, S and Barin, F and Chaillon, A and Marque-Juillet, S and Roque-Afonso, A.M and Haïm-Boukobza, S and Flandre, P and Grudé, M and Assoumou, L and Costagliola, D and ANRS AC11 Resistance Study Grp and ANRS AC11 Resistance Study Group
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 10/2014, Volume 70, Issue 5, pp. 1507 - 1512
Journal Article